<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=WAY-629</id>
	<title>WAY-629 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=WAY-629"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=WAY-629&amp;action=history"/>
	<updated>2026-04-26T21:47:06Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=WAY-629&amp;diff=5808451&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=WAY-629&amp;diff=5808451&amp;oldid=prev"/>
		<updated>2024-05-22T17:16:44Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:WAY 629.svg|thumb|WAY 629.svg]] &amp;#039;&amp;#039;&amp;#039;WAY-629&amp;#039;&amp;#039;&amp;#039; is a chemical compound that has been studied for its potential pharmacological properties. It is classified as a [[serotonin receptor]] agonist, specifically targeting the [[5-HT1A receptor]].&lt;br /&gt;
&lt;br /&gt;
==Chemical Properties==&lt;br /&gt;
WAY-629 is a synthetic compound with a molecular structure designed to interact with specific [[neurotransmitter]] receptors in the brain. The exact chemical formula and structure of WAY-629 are proprietary and have been the subject of various research studies.&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
WAY-629 functions primarily as an agonist at the [[5-HT1A receptor]], a subtype of the [[serotonin receptor]] family. Activation of the 5-HT1A receptor is known to have various effects on mood, anxiety, and cognition. This receptor is a target for several [[antidepressant]] and [[anxiolytic]] medications.&lt;br /&gt;
&lt;br /&gt;
==Research and Development==&lt;br /&gt;
WAY-629 has been investigated in preclinical studies to evaluate its efficacy and safety profile. These studies typically involve [[in vitro]] assays and [[animal model]]s to determine the compound&amp;#039;s pharmacokinetics and pharmacodynamics.&lt;br /&gt;
&lt;br /&gt;
==Potential Therapeutic Uses==&lt;br /&gt;
Given its action on the 5-HT1A receptor, WAY-629 has been explored for potential use in treating conditions such as [[depression]], [[anxiety disorders]], and other [[neuropsychiatric disorders]]. However, as of the latest updates, it has not yet been approved for clinical use.&lt;br /&gt;
&lt;br /&gt;
==Side Effects and Safety==&lt;br /&gt;
The safety profile of WAY-629 is still under investigation. Common side effects associated with 5-HT1A receptor agonists include [[nausea]], [[dizziness]], and [[fatigue]]. Long-term safety data are not yet available.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Serotonin]]&lt;br /&gt;
* [[5-HT1A receptor]]&lt;br /&gt;
* [[Neurotransmitter]]&lt;br /&gt;
* [[Pharmacology]]&lt;br /&gt;
* [[Antidepressant]]&lt;br /&gt;
* [[Anxiolytic]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Serotonin receptor agonists]]&lt;br /&gt;
[[Category:Experimental drugs]]&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>